MEDNAX Inc (NYSE:MD) shares gapped down prior to trading on Thursday . The stock had previously closed at $38.28, but opened at $36.64. MEDNAX shares last traded at $36.32, with a volume of 2412525 shares.
A number of research analysts have recently commented on the stock. ValuEngine cut shares of MEDNAX from a “sell” rating to a “strong sell” rating in a report on Thursday, November 1st. Zacks Investment Research raised shares of MEDNAX from a “sell” rating to a “hold” rating in a report on Monday, January 28th. Citigroup raised shares of MEDNAX from a “neutral” rating to a “buy” rating and set a $34.88 target price for the company in a report on Monday, January 14th. They noted that the move was a valuation call. Deutsche Bank assumed coverage on shares of MEDNAX in a report on Thursday, January 3rd. They issued a “hold” rating and a $34.00 target price for the company. Finally, UBS Group assumed coverage on shares of MEDNAX in a report on Friday, November 16th. They issued a “sell” rating and a $37.00 target price for the company. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company’s stock. MEDNAX presently has a consensus rating of “Hold” and an average price target of $46.07.
The firm has a market cap of $3.09 billion, a PE ratio of 11.53, a P/E/G ratio of 0.93 and a beta of 0.69. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67.
In related news, insider John C. Pepia sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $36.60, for a total value of $91,500.00. Following the completion of the transaction, the insider now owns 28,583 shares in the company, valued at approximately $1,046,137.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 2.70% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of MD. GHP Investment Advisors Inc. raised its holdings in MEDNAX by 19.8% during the 3rd quarter. GHP Investment Advisors Inc. now owns 9,775 shares of the company’s stock worth $456,000 after purchasing an additional 1,615 shares during the last quarter. Ardevora Asset Management LLP bought a new position in MEDNAX during the 3rd quarter worth approximately $9,892,000. Eagle Boston Investment Management Inc. raised its holdings in MEDNAX by 5.2% during the 3rd quarter. Eagle Boston Investment Management Inc. now owns 257,103 shares of the company’s stock worth $11,996,000 after purchasing an additional 12,595 shares during the last quarter. Oakbrook Investments LLC raised its holdings in MEDNAX by 33.3% during the 3rd quarter. Oakbrook Investments LLC now owns 11,600 shares of the company’s stock worth $541,000 after purchasing an additional 2,900 shares during the last quarter. Finally, Panagora Asset Management Inc. raised its holdings in MEDNAX by 1,005.5% during the 3rd quarter. Panagora Asset Management Inc. now owns 38,274 shares of the company’s stock worth $1,786,000 after purchasing an additional 34,812 shares during the last quarter. Institutional investors and hedge funds own 96.94% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “MEDNAX (MD) Shares Gap Down to $36.64” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/4134393/mednax-md-shares-gap-down-to-36-64.html.
MEDNAX Company Profile (NYSE:MD)
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services.
Read More: How Do Tariffs Affect Trade Balances?
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.